Home » Topics » BioWorld Science

BioWorld Science
RSS

Acceptance of Onco TCS NDA triggers payment to Elan

May 26, 2004

Yamanouchi and Fujisawa sign definitive merger agreement to form Astellas Pharma

May 26, 2004

Australian approval for Remodulin in pulmonary arterial hypertension

May 26, 2004

Novel dual lipid synthesis inhibitor effective for metabolic syndrome and dyslipidemia

May 26, 2004

Novel CDK2/cyclin A inhibitor effective antitumor agent in vivo

May 26, 2004

Potent and selective CCR5 antagonists effective against graft rejection in monkey

May 26, 2004

Enrollment under way in phase I study of NQO2 anticancer therapy

May 26, 2004

Studies show pregabalin to be safe and effective in treating postherpetic neuralgia

May 26, 2004

Efficacy and pharmacokinetics of Oxytrex in patients with chronic osteoarthritic pain

May 26, 2004

Further data on DepoMorphine in postoperative pain control

May 26, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 23, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
Psychedelic space expanding on Trump’s EO
BioWorld
Timothy Leary is dead, but he could be on the outside looking in with a smile on his face as U.S. President Donald Trump’s latest executive order (EO) fuels a...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...